US Patent 7704959 Azithromycin for the treatment of nodular acne
Patent 7704959 was granted and assigned to Dow Pharmaceutical Sciences on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+124 characters)
Article
Patent abstract
Azithromycin, administered systemically, is an effective treatment for nodules associated with acne vulgaris.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Barry Calvarese0
Bhaskar Chaudhuri0
David Wade Osborne0
Gordon Jay Dow0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07704959 Azithromycin for the treatment of nodular acne US Patent 7704959 Azithromycin for the treatment of nodular acne
Infobox
Patent Number
07704959
Patent Number
7704959
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07704959 Azithromycin for the treatment of nodular acne
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07704959
Date of patent
April 27, 2010
Patent application number
11635127
Date Filed
December 6, 2006
Patent primary examiner
Find more entities like US Patent 7704959 Azithromycin for the treatment of nodular acne
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
